First-Ever Pill For Postpartum Depression Is Up For FDA Approval This Week

A new treatment for postpartum depression, which affects about one in nine new mothers in the U.S., could be approved by the Food and Drug Administration this week.

The pill, called zuranolone, has shown to improve depression symptoms among new mothers as early as three days after they started it.

Support The Readers Bureau. Buy A T-Shirt Today (4 different colors)! click

Readers Bureau, Contributor

 Edited by Jesus Chan

 Do you want to add feedback to this story?

Please add a comment in the box below or send an email to Call us at 646-874-7976. SUBSCRIBE CLICK

Like our Facebook page

Follow us on Twitter